FDA Grants Premarket Approval for AccelStim Bone Growth Stimulation DeviceÂ
Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announces U.S. FDA pre-market approval for the AccelStim bone healing therapy Class III device.